Various manufacturing processes available and flexible batch sizes. Each process is equipped with multiple production function rooms, and each function room adopts an independent HVAC system to minimize cross-contamination during manufacturing of multiple products.
13 billion tablets/capsules and 100 million bottles of oral liquids
tablets, hard capsules , granules, dry suspensions, powders, glucocorticoid solids etc.
Oral liquids:
oral solutions, oral suspensions, syrups etc.
OEB4 high potent preparations.
Dosage forms: Tablets, Hard capsules, Granules, Dry suspension, Powde
Annual capacity: 3 billion tablets
Dosage forms: Tablets
Annual capacity: 50 million tablets
Dedicated for smaller scale-up batches and BE batches
Dosage forms: Tablets
Annual capacity: 500 million tablets
Dosage forms：Oral solution, Oral suspension & Syrup
Annual capacity：10 million bottles
Designed annual capacity:800 million tablets
For OEB4 oral solid preparations
Designed annual capacity:1 billion tablets
Class D clean workshop:2500 m2
For oral solutions and suspensions
60-300 ml, annual production capacity up to 20 million bottles at phase lWhich can be expanded to 100 million bottles within six months if needed For both glass andplastic bottles pack
Class D clean workshop: 13,000 m2
For tablets,capsules, granules, powders and pellets
For large volume products with annual volume more than 20 million tablets Annual production capacity up to 2 billior tablets/capsules at Phasel Which can be expanded to 10 billion tablets/capsules within six months if needed
About 18,000 m2
Can be customized to build 15-20 workshops dedicated for special products
Copyright © 2025HUAYI PHARMA All Rights Reserved. 皖ICP备12345678号
Technical Support: Govland.cn
加载中...